These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD. Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760 [Abstract] [Full Text] [Related]
26. Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas. Tsuzuki H, Sunaga H, Ito T, Narita N, Sugimoto C, Fujieda S. Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1071-8. PubMed ID: 16365220 [Abstract] [Full Text] [Related]
30. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Ho JW, Pang RW, Lau C, Sun CK, Yu WC, Fan ST, Poon RT. Hepatology; 2006 Oct; 44(4):836-43. PubMed ID: 17006919 [Abstract] [Full Text] [Related]
37. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma. Moriyama A, Masumoto A, Nanri H, Tabaru A, Unoki H, Imoto I, Ikeda M, Otsuki M. Am J Gastroenterol; 1997 Sep; 92(9):1520-3. PubMed ID: 9317076 [Abstract] [Full Text] [Related]